A5055931813- Glioma Diagnosis and Treatment
- Vascular Malformations Diagnosis and Treatment
- Meningioma and schwannoma management
- Liver Disease Diagnosis and Treatment
- Hepatitis C virus research
- Advanced Neuroimaging Techniques and Applications
- Glycosylation and Glycoproteins Research
- Hepatitis B Virus Studies
- Lysosomal Storage Disorders Research
- Glycogen Storage Diseases and Myoclonus
- MRI in cancer diagnosis
First Affiliated Hospital of Fujian Medical University
2018-2024
Fujian Medical University
2018-2024
<h3>BACKGROUND AND PURPOSE:</h3> Anaplastic pleomorphic xanthoastrocytoma, which has been recently defined as a distinct entity in the 2016 World Health Organization classification, may exhibit aggressive clinical behavior and relatively worse prognosis than xanthoastrocytoma. This study aimed to investigate whether there were any differences MR imaging characteristics between these 2 tumors. <h3>MATERIALS METHODS:</h3> retrospective included 9 patients with anaplastic xanthoastrocytoma 10...
<h3>BACKGROUND AND PURPOSE:</h3> An accurate evaluation of the World Health Organization grade is critical in pediatric intracranial tumors. Our aim was to explore correlations between parameters derived from conventional DWI, intravoxel incoherent motion, and diffusional kurtosis imaging with histopathologic features evaluate accuracy diffusion for grading <h3>MATERIALS METHODS:</h3> Fifty-four patients histologically proved tumors who underwent were recruited. The DWI (ADC), motion (pure...
Abstract Objective Expand genetic screening for atypical Type I sialidosis (ST‐1) could address its underdiagnosed in both progressive myoclonic ataxia (PMA) and patients. To evaluate the potential founder effect of mutation population. Methods We enrolled 231 patients with PMA or from First Affiliated Hospital Fujian Medical University. Through Whole Exome Sequencing Sanger sequencing, we identified causative gene Haplotype analysis was employed to explore a NEU1 c.544A>G mutation....
Objective: To investigate the efficacy of sequential therapy with telbivudine in treatment HBeAg-positive chronic hepatitis B (CHB) patients partial response after a standard course interferon therapy. Methods: A retrospective cohort study was performed for 58 CHB at end (48-60 weeks) from January 2009 to December 2013. According whether used sequentially or withdrawn treatment, were divided into group and withdrawal group, two groups compared terms biochemical, virological, serological...